3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Salivary Gland Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Extensive Stage Small Cell Lung Carcinoma
1
Down Syndrome
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Nivolumab
21
pembrolizumab
18
Ipilimumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
7
trametinib
5
binimetinib
5
Opdualag
5
relatlimab
4
dabrafenib
4
atezolizumab
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
Biopsy
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
aldesleukin
2
X-Rays
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Radiotherapy, Conformal
×
30 days
×
Clear all
No trials found.